GRFS
Price
$9.93
Change
+$0.06 (+0.61%)
Updated
Aug 29, 04:01 PM (EDT)
Capitalization
8.55B
69 days until earnings call
MIRA
Price
$1.38
Change
-$0.02 (-1.43%)
Updated
Aug 29, 04:07 PM (EDT)
Capitalization
26.12M
5 days until earnings call
Interact to see
Advertisement

GRFS vs MIRA

Header iconGRFS vs MIRA Comparison
Open Charts GRFS vs MIRABanner chart's image
Grifols SA
Price$9.93
Change+$0.06 (+0.61%)
Volume$100
Capitalization8.55B
MIRA Pharmaceuticals
Price$1.38
Change-$0.02 (-1.43%)
Volume$100
Capitalization26.12M
GRFS vs MIRA Comparison Chart in %
Loading...
GRFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MIRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GRFS vs. MIRA commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRFS is a Buy and MIRA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (GRFS: $9.87 vs. MIRA: $1.40)
Brand notoriety: GRFS and MIRA are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GRFS: 73% vs. MIRA: 5%
Market capitalization -- GRFS: $8.55B vs. MIRA: $26.12M
GRFS [@Pharmaceuticals: Major] is valued at $8.55B. MIRA’s [@Pharmaceuticals: Major] market capitalization is $26.12M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $656.17B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $88.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GRFS’s FA Score shows that 1 FA rating(s) are green whileMIRA’s FA Score has 0 green FA rating(s).

  • GRFS’s FA Score: 1 green, 4 red.
  • MIRA’s FA Score: 0 green, 5 red.
According to our system of comparison, GRFS is a better buy in the long-term than MIRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GRFS’s TA Score shows that 3 TA indicator(s) are bullish while MIRA’s TA Score has 3 bullish TA indicator(s).

  • GRFS’s TA Score: 3 bullish, 5 bearish.
  • MIRA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both GRFS and MIRA are a bad buy in the short-term.

Price Growth

GRFS (@Pharmaceuticals: Major) experienced а -2.08% price change this week, while MIRA (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.84%. For the same industry, the average monthly price growth was +1.29%, and the average quarterly price growth was +11.90%.

Reported Earning Dates

GRFS is expected to report earnings on Nov 06, 2025.

MIRA is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.84% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GRFS($8.55B) has a higher market cap than MIRA($26.1M). GRFS YTD gains are higher at: 37.180 vs. MIRA (22.807). GRFS has higher annual earnings (EBITDA): 1.62B vs. MIRA (-7.87M). GRFS has more cash in the bank: 566M vs. MIRA (730K). MIRA has less debt than GRFS: MIRA (0) vs GRFS (8.82B). GRFS has higher revenues than MIRA: GRFS (7.45B) vs MIRA (0).
GRFSMIRAGRFS / MIRA
Capitalization8.55B26.1M32,759%
EBITDA1.62B-7.87M-20,557%
Gain YTD37.18022.807163%
P/E Ratio19.18N/A-
Revenue7.45B0-
Total Cash566M730K77,534%
Total Debt8.82B0-
FUNDAMENTALS RATINGS
GRFS: Fundamental Ratings
GRFS
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GRFSMIRA
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 16 days ago
73%
Bullish Trend 17 days ago
88%
Declines
ODDS (%)
Bearish Trend 9 days ago
74%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GRFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MIRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CICAX65.640.28
+0.43%
American Funds Invmt Co of Amer 529A
FSMEX60.13N/A
N/A
Fidelity Select Medical Tech and Devcs
EIFGX31.19N/A
N/A
Eaton Vance Focused Growth Opps I
GSRRX11.70N/A
N/A
Goldman Sachs Rising Dividend Gr R
INTIX13.26N/A
N/A
Voya International Index Port S

GRFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRFS has been closely correlated with GIKLY. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if GRFS jumps, then GIKLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRFS
1D Price
Change %
GRFS100%
+0.71%
GIKLY - GRFS
68%
Closely correlated
N/A
GIFOF - GRFS
37%
Loosely correlated
N/A
PFE - GRFS
28%
Poorly correlated
-1.87%
BIIB - GRFS
27%
Poorly correlated
-2.72%
GILD - GRFS
26%
Poorly correlated
-1.19%
More

MIRA and

Correlation & Price change

A.I.dvisor tells us that MIRA and AMRN have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MIRA and AMRN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIRA
1D Price
Change %
MIRA100%
+2.19%
AMRN - MIRA
21%
Poorly correlated
-0.42%
OGN - MIRA
15%
Poorly correlated
-0.22%
GRFS - MIRA
8%
Poorly correlated
+0.71%
RHHBF - MIRA
8%
Poorly correlated
-3.04%
RHHVF - MIRA
8%
Poorly correlated
-1.80%
More